News

New research from Mayo Clinic finds that the presence of a specific genetic mutation — KRAS circulating tumor DNA (ctDNA) — strongly indicates a higher risk of cancer spread and worse survival rates for patients with pancreatic ductal adenocarcinoma.

The unknown microorganisms likely used marble and limestone found in Namibia, Oman, and Saudi Arabia as a habitat.

A study from St. Jude Children’s Research Hospital reveals that the protein VDAC2 acts as a “signal jammer” in tumors, preventing immune system communication. By removing VDAC2, tumors became more sensitive to immunotherapy.

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection.

Researchers used reinforcement learning to show how flexible responses can substantially increase the cost-effectiveness of defenses for cities like New York against climate change.

New research, in a rat model, finds that both biological sex and mitochondrial DNA – the small set of genes inherited only from mothers – play a key role in how gut bacteria change over time.

A study led by NYU Langone Health discovered that oxytocin delays embryo development in stressed mice, providing insights into diapause. This phenomenon, known to occur in various species, may help preserve resources for maternal care.

Krill are a keystone species in the Antarctic, but their population is moving further south due to climate change.

IMFINZI^TM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemoradiation therapy.

Scientists developed a promising gene replacement therapy for Dravet syndrome in mice. The therapy alleviated symptoms without toxicity or side effects, marking a significant step forward in treating this rare form of epilepsy.